A new SARS-CoV-2 vaccine candidate, developed by giving a key protein's gene a ride into the body while encased in a measles vaccine, has been shown to produce a strong immune response and prevent SARS-CoV-2 infection and ...
Mar 10, 2021
0
267
Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease ...
Mar 2, 2021
0
7
US biotech firm Moderna said Wednesday that doses of its new COVID-19 vaccine candidate aimed at the South African coronavirus variant had been shipped to the US National Institutes of Health for testing.
Feb 24, 2021
0
5
The Altimmune Inc. vaccine candidate that was tested preclinically at the University of Alabama at Birmingham last year is expected to start patient enrollment for its Phase 1 clinical trial next week.
Feb 19, 2021
0
13
French pharmaceutical startup Valneva had big news in September: a government contract for 60 million doses of its coronavirus vaccine candidate.
Feb 7, 2021
0
4
While the Pfizer and Moderna COVID-19 vaccines continue to be administered across the United States under an emergency authorization status, ongoing coronavirus vaccine research and development remain critical to the fight ...
Jan 25, 2021
0
2
Staphylococcus aureus (S. aureus) ranks among the globally most important causes of infections in humans and is considered a dreaded hospital pathogen. Active and passive immunization against multi-resistant strains is seen ...
Jan 21, 2021
0
3
Healthcare providers must be able to explain the latest data supporting the safety and efficacy of vaccines for coronavirus disease 2019 (COVID-19) so they can strongly encourage vaccination when appropriate while acknowledging ...
Jan 19, 2021
0
3
A vaccine candidate made by China's Sinovac is 78% effective in protecting against COVID-19, according to results of a study announced Thursday by Brazilian state health officials seeking federal approval of the shot.
Jan 7, 2021
0
1
German pharmaceutical firms Bayer and CureVac said Thursday that they have joined forces in the development and supply of CureVac's COVID-19 vaccine candidate.
Jan 7, 2021
0
2
